Experiment 185170

Worktypes

PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

SULFOBACIN A

Details

PropertyValue
Pharmacology
VON WILLEBRAND'S FACTOR BINDING INHIBITION
OrganismChryseobacterium species (ACHROMOBACTERIACEAE)
CitationKAMIYAMA,T: UMINO,T: SATOH,T: SAWAIRI,S: SHIRANE,M: OHSHIMA,S: YOKOSE,K:. (1995). SULFOBACINS A AND B, NOVEL VON WILLEBRAND FACTOR RECEPTOR ANTAGONISTS. I. PRODUCTION, ISOLATION, CHARACTERIZATION AND BIOLOGICAL ACTIVITIES.. 48(9)
Amount utilized
Compound isolated
DiseaseINHIBITS BINDING OF VWB TO GPIB/IX OF PLATELETS.
Dose amount0.47 MICROMOLS
Number2
Qualitative resultACTIVE
AnimalHUMAN ADULT
Dose expressionIC50